<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37131909</PMID><DateRevised><Year>2023</Year><Month>10</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">2452-0918</ISSN><JournalIssue CitedMedium="Print"><Volume>21</Volume><PubDate><Year>2023</Year><Season>May-Jun</Season></PubDate></JournalIssue><Title>Clinical epidemiology and global health</Title><ISOAbbreviation>Clin Epidemiol Glob Health</ISOAbbreviation></Journal><ArticleTitle>Significant impact of COVID-19 pandemic on the circulation of respiratory viruses in Tunisia, 2020-2021.</ArticleTitle><Pagination><StartPage>101306</StartPage><MedlinePgn>101306</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.cegh.2023.101306</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">The COVID-19 pandemic changed the typical patterns of respiratory infections globally. While SARS-CoV-2 illness exhibited explosive growth since 2020, the activity of other respiratory viruses fell below historical seasonal norms. The objective of this study was to assess the prevalence of seasonal respiratory viruses during the COVID-19 pandemic in Tunisia.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">This is a retrospective cross-sectional study including 284 nasopharyngeal samples tested negative for SARS-CoV-2 during the period October 2020-May 2021. All samples were screened for fifteen common respiratory viruses. Either a fast syndromic approach using Biofire FILM ARRAY respiratory 2.1 (RP2.1) Panel, or end-point multiplex RT-PCRs detecting RNA viruses and Real-Time PCR detecting Adenoviruses were used.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Overall, 30.6% (87/284) of samples were positive for at least one virus. Mixed infections were detected in 3.4% of positive cases. <i>Enterovirus/Rhinovirus</i> (HEV/HRV) was the most detected virus throughout the study period, especially during December 2020 (33.3% of all HEV/HRV being detected). During the 2020-2021 winter season, neither <i>Respiratory Syncytial Virus</i> nor <i>Influenza Viruses</i> circulation was observed. <i>Metapneumovirus</i> and <i>Parainfluenza Viruses</i> infections were detected during the spring season. The highest rate of respiratory viruses detection was observed in children and adults aged [0-10] years (50%) and [31-40] years (40%). HEV/HRV was the most detected virus regardless of age group.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Public health measures used to prevent SARS-CoV-2 spread in Tunisia were also effective to reduce transmission of the other respiratory viruses, especially Influenza. The higher resistance of HEV/HRV in the environment could explain their predominance and continuous circulation during this period.</AbstractText><CopyrightInformation>© 2023 The Authors.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Taktak</LastName><ForeName>Awatef</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Laboratory of Microbiology, Habib Bourguiba University-Hospital, Rue El Ferdaous, 3003, Sfax, Tunisia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Molecular Biotechnology of Eukaryotes, Center of Biotechnology of Sfax, University of Sfax, Sidi Mansour Street Km 6, BP 1177, 3038, Sfax, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smaoui</LastName><ForeName>Fahmi</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Laboratory of Microbiology, Habib Bourguiba University-Hospital, Rue El Ferdaous, 3003, Sfax, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chtourou</LastName><ForeName>Amel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Laboratory of Microbiology, Habib Bourguiba University-Hospital, Rue El Ferdaous, 3003, Sfax, Tunisia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, University of Sfax, Avenue Majida Boulila, 3029, Sfax, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maâloul</LastName><ForeName>Mouna</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Laboratory of Microbiology, Habib Bourguiba University-Hospital, Rue El Ferdaous, 3003, Sfax, Tunisia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, University of Sfax, Avenue Majida Boulila, 3029, Sfax, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karray-Hakim</LastName><ForeName>Héla</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Laboratory of Microbiology, Habib Bourguiba University-Hospital, Rue El Ferdaous, 3003, Sfax, Tunisia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, University of Sfax, Avenue Majida Boulila, 3029, Sfax, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hammami</LastName><ForeName>Adnene</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Laboratory of Microbiology, Habib Bourguiba University-Hospital, Rue El Ferdaous, 3003, Sfax, Tunisia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, University of Sfax, Avenue Majida Boulila, 3029, Sfax, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fki-Berrajah</LastName><ForeName>Lamia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Laboratory of Microbiology, Habib Bourguiba University-Hospital, Rue El Ferdaous, 3003, Sfax, Tunisia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, University of Sfax, Avenue Majida Boulila, 3029, Sfax, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gargouri</LastName><ForeName>Saba</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Laboratory of Microbiology, Habib Bourguiba University-Hospital, Rue El Ferdaous, 3003, Sfax, Tunisia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, University of Sfax, Avenue Majida Boulila, 3029, Sfax, Tunisia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>India</Country><MedlineTA>Clin Epidemiol Glob Health</MedlineTA><NlmUniqueID>101608821</NlmUniqueID><ISSNLinking>2213-3984</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Molecular assay</Keyword><Keyword MajorTopicYN="N">Prevalence</Keyword><Keyword MajorTopicYN="N">Respiratory viruses</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">Tunisia</Keyword></KeywordList><CoiStatement>There are no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>4</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>3</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>3</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>3</Day><Hour>2</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>4</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37131909</ArticleId><ArticleId IdType="pmc">PMC10132842</ArticleId><ArticleId IdType="doi">10.1016/j.cegh.2023.101306</ArticleId><ArticleId IdType="pii">S2213-3984(23)00093-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kong W.H., Li Y., Peng M.W., et al. SARS-CoV-2 detection in patients with influenza-like illness. Nat Microbiol. 2020;5(5):675–678. doi: 10.1038/s41564-020-0713-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-020-0713-1</ArticleId><ArticleId IdType="pubmed">32265517</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu B., Guo H., Zhou P., Shi Z.L. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol. 2021;19(3):141–154. doi: 10.1038/s41579-020-00459-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-020-00459-7</ArticleId><ArticleId IdType="pmc">PMC7537588</ArticleId><ArticleId IdType="pubmed">33024307</ArticleId></ArticleIdList></Reference><Reference><Citation>Chow E.J., Uyeki T.M., Chu H.Y. The effects of the COVID-19 pandemic on community respiratory virus activity. Nat Rev Microbiol. 2022;17:1–16. doi: 10.1038/s41579-022-00807-9. Published online October.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00807-9</ArticleId><ArticleId IdType="pmc">PMC9574826</ArticleId><ArticleId IdType="pubmed">36253478</ArticleId></ArticleIdList></Reference><Reference><Citation>Khanolkar R.A., Trajkovski A., Agarwal A., Pauls M.A., Lang E.S. Emerging evidence for non-pharmacologic interventions in reducing the burden of respiratory illnesses. Intern Emerg Med. 2022;17(3):639–644. doi: 10.1007/s11739-022-02932-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11739-022-02932-y</ArticleId><ArticleId IdType="pmc">PMC8814568</ArticleId><ArticleId IdType="pubmed">35119570</ArticleId></ArticleIdList></Reference><Reference><Citation>Flaxman S., Mishra S., Gandy A., et al. Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe. Nature. 2020;584(7820):257–261. doi: 10.1038/s41586-020-2405-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2405-7</ArticleId><ArticleId IdType="pubmed">32512579</ArticleId></ArticleIdList></Reference><Reference><Citation>Haug N., Geyrhofer L., Londei A., et al. Ranking the effectiveness of worldwide COVID-19 government interventions. Nat Human Behav. 2020;4(12):1303–1312. doi: 10.1038/s41562-020-01009-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41562-020-01009-0</ArticleId><ArticleId IdType="pubmed">33199859</ArticleId></ArticleIdList></Reference><Reference><Citation>Chouikha A., Fares W., Laamari A., et al. Molecular epidemiology of SARS-CoV-2 in Tunisia (North Africa) through several successive waves of COVID-19. Viruses. 2022;14(3):624. doi: 10.3390/v14030624.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14030624</ArticleId><ArticleId IdType="pmc">PMC8956073</ArticleId><ArticleId IdType="pubmed">35337031</ArticleId></ArticleIdList></Reference><Reference><Citation>Du X., Wu G., Zhu Y., Zhang S. Exploring the epidemiological changes of common respiratory viruses since the COVID-19 pandemic: a hospital study in Hangzhou, China. Arch Virol. 2021;166(11):3085–3092. doi: 10.1007/s00705-021-05214-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-021-05214-8</ArticleId><ArticleId IdType="pmc">PMC8417671</ArticleId><ArticleId IdType="pubmed">34480636</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Q.S., Wood T., Jelley L., et al. Impact of the COVID-19 nonpharmaceutical interventions on influenza and other respiratory viral infections in New Zealand. Nat Commun. 2021;12:1001. doi: 10.1038/s41467-021-21157-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-21157-9</ArticleId><ArticleId IdType="pmc">PMC7881137</ArticleId><ArticleId IdType="pubmed">33579926</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellau-Pujol S., Vabret A., Legrand L., et al. Development of three multiplex RT-PCR assays for the detection of 12 respiratory RNA viruses. J Virol Methods. 2005;126(1):53–63. doi: 10.1016/j.jviromet.2005.01.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jviromet.2005.01.020</ArticleId><ArticleId IdType="pmc">PMC7112904</ArticleId><ArticleId IdType="pubmed">15847919</ArticleId></ArticleIdList></Reference><Reference><Citation>Berrajah L., Slama L.B., Khbou I., et al. Virus et bactéries atypiques détectés dans les infections respiratoires basses communautaires de l’enfant dans la région de Sfax en Tunisie. Bull Société Pathol Exot. 2018;111(2):90. doi: 10.3166/bspe-2018-0024.</Citation><ArticleIdList><ArticleId IdType="doi">10.3166/bspe-2018-0024</ArticleId><ArticleId IdType="pubmed">30789240</ArticleId></ArticleIdList></Reference><Reference><Citation>Dina J., Nguyen E., Gouarin S., et al. Development of duplex real-time PCR for detection of two DNA respiratory viruses. J Virol Methods. 2009;162(1-2):119–125. doi: 10.1016/j.jviromet.2009.07.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jviromet.2009.07.025</ArticleId><ArticleId IdType="pmc">PMC7112853</ArticleId><ArticleId IdType="pubmed">19654024</ArticleId></ArticleIdList></Reference><Reference><Citation>Vabret A., Dina J., Gouarin S., Petitjean J., Corbet S., Freymuth F. Detection of the new human coronavirus HKU1: a report of 6 cases. Clin Infect Dis Off Publ Infect Dis Soc Am. 2006;42(5):634–639. doi: 10.1086/500136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/500136</ArticleId><ArticleId IdType="pmc">PMC7107802</ArticleId><ArticleId IdType="pubmed">16447108</ArticleId></ArticleIdList></Reference><Reference><Citation>Vabret A., Mourez T., Dina J., et al. Human coronavirus NL63, France. Emerg Infect Dis. 2005;11(8):1225–1229. doi: 10.3201/eid1108.050110.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1108.050110</ArticleId><ArticleId IdType="pmc">PMC3320486</ArticleId><ArticleId IdType="pubmed">16102311</ArticleId></ArticleIdList></Reference><Reference><Citation>Cowling B.J., Ali S.T., Ng T.W.Y., et al. Impact assessment of non-pharmaceutical interventions against coronavirus disease 2019 and influenza in Hong Kong: an observational study. Lancet Public Health. 2020;5(5):e279–e288. doi: 10.1016/S2468-2667(20)30090-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2468-2667(20)30090-6</ArticleId><ArticleId IdType="pmc">PMC7164922</ArticleId><ArticleId IdType="pubmed">32311320</ArticleId></ArticleIdList></Reference><Reference><Citation>Moussi A.E., Pozo F., Kacem M.A.B.H., et al. Virological surveillance of influenza viruses during the 2008–09, 2009–10 and 2010–11 seasons in Tunisia. PLoS One. 2013;8(9) doi: 10.1371/journal.pone.0074064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0074064</ArticleId><ArticleId IdType="pmc">PMC3777972</ArticleId><ArticleId IdType="pubmed">24069267</ArticleId></ArticleIdList></Reference><Reference><Citation>Yazidi R., Aissi W., Bouguerra H., et al. Evaluation of the influenza-like illness surveillance system in Tunisia, 2012–2015. BMC Publ Health. 2019;19(1):694. doi: 10.1186/s12889-019-7035-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-019-7035-3</ArticleId><ArticleId IdType="pmc">PMC6555026</ArticleId><ArticleId IdType="pubmed">31170955</ArticleId></ArticleIdList></Reference><Reference><Citation>Park K.Y., Seo S., Han J., Park J.Y. Respiratory virus surveillance in Canada during the COVID-19 pandemic: an epidemiological analysis of the effectiveness of pandemic-related public health measures in reducing seasonal respiratory viruses test positivity. PLoS One. 2021;16(6) doi: 10.1371/journal.pone.0253451.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0253451</ArticleId><ArticleId IdType="pmc">PMC8213179</ArticleId><ArticleId IdType="pubmed">34143839</ArticleId></ArticleIdList></Reference><Reference><Citation>Takashita E., Kawakami C., Momoki T., et al. Increased risk of rhinovirus infection in children during the coronavirus disease‐19 pandemic. Influenza Other Respir Viruses. 2021;15(4):488–494. doi: 10.1111/irv.12854.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/irv.12854</ArticleId><ArticleId IdType="pmc">PMC8189209</ArticleId><ArticleId IdType="pubmed">33715290</ArticleId></ArticleIdList></Reference><Reference><Citation>Leung N.H.L., Chu D.K.W., Shiu E.Y.C., et al. Respiratory virus shedding in exhaled breath and efficacy of face masks. Nat Med. 2020;26(5):676–680. doi: 10.1038/s41591-020-0843-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0843-2</ArticleId><ArticleId IdType="pmc">PMC8238571</ArticleId><ArticleId IdType="pubmed">32371934</ArticleId></ArticleIdList></Reference><Reference><Citation>Casalegno J.S., Ottmann M., Bouscambert-Duchamp M., Valette M., Morfin F., Lina B. Impact of the 2009 influenza A(H1N1) pandemic wave on the pattern of hibernal respiratory virus epidemics, France, 2009. Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull. 2010;15(6)</Citation><ArticleIdList><ArticleId IdType="pubmed">20158981</ArticleId></ArticleIdList></Reference><Reference><Citation>Casalegno J.S., Ottmann M., Duchamp M.B., et al. Rhinoviruses delayed the circulation of the pandemic influenza A (H1N1) 2009 virus in France. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis. 2010;16(4):326–329. doi: 10.1111/j.1469-0691.2010.03167.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1469-0691.2010.03167.x</ArticleId><ArticleId IdType="pubmed">20121829</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>